Seeking Alpha

BioMimetic Therapeutics Inc. (BMTI)

()

Comments on BMTI

  • BioMed News Bytes: Progenics, Somanetics, Ziopharm, Cardium, pSivida, BioMimetic Therapeutics [View article]
    LONG ZIOPHARM. iNTERSTING COMPANY.Hopefully the success in the clinic will translate into a commercial pairing. They also have an... More »
    Comment by Wall Street Teacher
    Oct 18 20:23 pm |
    Rating: 0 0
  • BioMed News Bytes: Progenics, Somanetics, Ziopharm, Cardium, pSivida, BioMimetic Therapeutics [View article]
    atlantis43, it currently contains 412 entries, last updated by me to reflect FDA Advisory Panel meeting today on Acorda's experimental... More »
    Comment by Mike Havrilla
    Oct 14 17:40 pm |
    Rating: 0 0
  • BioMed News Bytes: Progenics, Somanetics, Ziopharm, Cardium, pSivida, BioMimetic Therapeutics [View article]
    what ever happened to the FDA approval calendar that Mike Havrilla edited?
    Comment by atlantis43
    Oct 14 17:28 pm |
    Rating: 0 0
  • Premarket gainers: CNO +22%. BMTI +12%. UEC +11%. ACAS +10%. PLUG +7%. FAS +6%. RTP +5%. CIEN... [View news story]
    believe you're right. Could even touch the magic 10,000 mark. If it should touch 10 grand, how many programs are set to buy at that... More »
    Comment by Niner
    Oct 14 09:16 am |
    Rating: 0 0
  • Premarket gainers: CNO +22%. BMTI +12%. UEC +11%. ACAS +10%. PLUG +7%. FAS +6%. RTP +5%. CIEN... [View news story]
    there has been much talk about the double top, and with an opening like this, so much for the double top concept
    Comment by DDPearson
    Oct 14 09:04 am |
    Rating: +1 0
  • FDA Calendar: 2H09 Binary Event Trades [View article]
    BIEL stated in 6/19/09 PR they have about 720 million shares of stock outstanding, but stock price has still increased by over 700% in... More »
    Comment by Mike Havrilla
    Jul 28 09:13 am |
    Rating: 0 0
  • FDA Calendar: 2H09 Binary Event Trades [View article]
    Even if its true(doubtful), its has a perfect product, at an excellent time, no debt, and high margins.
    Comment by Doug R
    Jul 28 07:33 am |
    Rating: 0 0
  • FDA Calendar: 2H09 Binary Event Trades [View article]
    I would advise extreme caution on BIEL. In the first quarter of 2009 alone (January-March) the company nearly doubled its shares... More »
    Comment by Dan Weiss
    Jul 27 22:30 pm |
    Rating: 0 0
  • 15 Overvalued Small Caps from Russell 2000 [View article]
    I happened to buy exel the same day your article claimed it to be overvalued and sell. I said it then and now I'll confirm, throw away... More »
    Comment by bramps
    Jul 26 00:44 am |
    Rating: 0 0
  • 15 Overvalued Small Caps from Russell 2000 [View article]
    SevePC 1: Value Exp 0 I know this is a short time view, but thought would point it out. Since this article was written on July 8,... More »
    Comment by CRZ
    Jul 24 17:33 pm |
    Rating: 0 0
  • 15 Overvalued Small Caps from Russell 2000 [View article]
    I agree with sevepc..... JAV should not be on this list. I suppose after the PDUFA you could re-evaluate, but until then how can you... More »
    Comment by BambamPoop
    Jul 15 22:56 pm |
    Rating: 0 0
  • 15 Overvalued Small Caps from Russell 2000 [View article]
    Several of these are special situations. Applying formulas ignores fairly important company or industry dynamics that should be... More »
    Comment by satyr
    Jul 9 14:32 pm |
    Rating: +3 0
  • 15 Overvalued Small Caps from Russell 2000 [View article]
    How you can include drug/diagnostic development stage companies in this list is beyond comprehension.
    Comment by SevePC
    Jul 8 18:00 pm |
    Rating: +3 0
  • Seven New Extreme Biotech Trades [View article]
    JAV also has a intranasal ketamine product called Ereska with phase III data due in next few weeks and plan to file an NDA for this as... More »
    Comment by drgmoney
    Jun 19 14:00 pm |
    Rating: 0 0
  • Seven New Extreme Biotech Trades [View article]
    BPAX has just launched Elestrin. Possible 10-20% profits and a $144 million milestone payment. The maximun market potential sales per... More »
    Comment by Roy Manning
    Jun 18 11:26 am |
    Rating: +2 0